Zhi Tong Cai Jing·2025-11-02 12:27Major Developments - Inhibrx announced positive results from the Phase II clinical trial of ozekibart for treating sarcoma, with plans to submit a Biologics License Application (BLA) by 2026 [1] - Junsheng Pharmaceutical-B completed Phase III clinical research for the innovative anti-inflammatory metabolic regulator HTD1801, demonstrating sustained benefits and safety over 52 weeks for type 2 diabetes [1] - China Railway Construction plans to invest 11 billion yuan to acquire stakes in several subsidiaries, including approximately 18.38% in China Railway 11th Bureau and 14.36% in China Railway Construction [1] - Ruifeng New Energy plans to deploy around 340,000 improved clean stoves in Laos, expecting a total carbon dioxide equivalent reduction of approximately 2.7 million tons over ten years [1] - Tanmu Carpenter is shifting its strategy from single product sales to a comprehensive output of cultural communication and brand value in Beijing [1] - China Tongru's breakthrough in key raw material technology for breath diagnostics positions it as a leader in the complete industrial chain of breath testing products [1] - Empire Technology Group signed a memorandum of understanding with Guanghe Xingyun to collaborate on developing AI comic dramas that reflect esports IP spirit [1] Financial Performance - AIA Group reported a 25% year-on-year increase in new business value for Q3, reaching 1.476 billion USD, with double-digit growth in 11 markets [1] - Eagle Precision achieved approximately 1.361 billion HKD in revenue for Q3, marking a 16.8% year-on-year growth [1] - Chery Automobile reported a profit attributable to shareholders of 14.365 billion yuan for the first three quarters, up 28.01% year-on-year [1] - Dongfeng Group recorded a net loss attributable to shareholders of approximately 1.882 billion yuan for Q3, a year-on-year increase of about 2.68 times [1] - Bohai Bank reported a net profit of 4.988 billion yuan for the first three quarters, an increase of 4.66% year-on-year [1] - Zhejiang Huhangyong reported a profit attributable to shareholders of 4.19 billion yuan for Q3, reflecting a 1.5% year-on-year growth [1] - BYD's sales of new energy vehicles reached approximately 3.7019 million units in the first ten months, representing a year-on-year growth of 13.88% [1]